Millions are Taking a Drug that Falls Short of its Promise to Lower Risk of #HeartAttack

“While #Fibrates such as #Gemfibrozil (#Lopid) and #Fenofibrate are proven to lower triglyceride levels, which can serve as a biomarker for #Cardiovascular disease risk, several major clinical studies from the past 20 years have failed to show a benefit of #fenofibrates over and above statins in further reducing #heart-related events.”

#FDA
https://medcitynews.com/2024/09/millions-are-taking-a-drug-that-falls-short-of-its-promise-to-lower-risk-of-heart-attack/

Millions are Taking a Drug that Falls Short of its Promise to Lower Risk of Heart Attack

While fibrates are proven to lower triglyceride levels, which can serve as a biomarker for cardiovascular disease risk, several major clinical studies from the past 20 years have failed to show a benefit of fenofibrates over and above statins in further reducing heart-related events. 

MedCity News
New Blog: This drug is unusual in that one person took it when first diagnosed, and did not need to inject insulin for years. Now that is just one person, which is why this clinical trial is so interesting. We will get much better data. #Fenofibrate
https://cureresearch4type1diabetes.blogspot.com/2024/05/fenofibrate-starts-phase-ii-trial.html?spref=tw #T1D #type1diabetes
Fenofibrate Starts A Phase-IIΔ Trial

Fenofibrate (also spelled Phenofibrate) is commonly prescribed for high cholesterol and high triglycerides. In 2017, it was the 70th most ...

Fenofibrate

Fenofibrate is affecting me the same awful way that Lipitor did, back in the day. If triglycerides are the problem underlying my pain, this medication doesn’t seem to be the answer.